Ledger.Open graph →
SEC Form D · filed July 25, 2014

NexImmune, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GAITHERSBURG, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Keyur Sathe · Dallas, TXDirectorEmmett Moore · Dallas, TXDirectorClaude Prestidge · Dallas, TXExec · DirectorRand Sperry · Irvine, CADirectorAmanda S. Jean-Baptiste · London, United KingdomExec · DirectorJohn A. Van-Wyk · London, United KingdomExec · DirectorRonald E. Bell · London, United KingdomDirectorDavid, Jr. D. Peete · Arlington, VAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗